The IBMISPS Pioneer Award is presented to companies and individuals who lead the fight for scientific excellence in research, development and education. IBMISPS now honors GE Healthcare for its excellence and efforts to promote the highest standards in technology development and patient care.
“GE Healthcare’s unique contributions to the science of imaging in general have been translated to clinically important advances in the diagnosis and treatment of patients with brain diseases,” said Babak Kateb, Chairman of the Board, Founder and Executive Director, International Brain Mapping & Intraoperative Surgical Planning Society (IBMISPS).
IBMISPS is specifically dedicated to the advancement of intra-operative surgical planning and brain mapping for the treatment of brain and spinal cord injuries and diseases.
“GE Healthcare is very proud to accept this award from the International Brain Mapping and Intraoperative Surgical Planning Society,” said Mark Vachon, President and CEO of GE Healthcare’s Global Diagnostic Imaging Business. “Organizations such as IBMISPS are critical in guiding users and regulators through future developments in healthcare, including image guided therapy. GE Healthcare is committed to introducing breakthrough technologies ensure the most effective clinical outcomes in surgery, but also enable an ‘Early Health’ model of care in the future, focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention.”
The award ceremony is scheduled for the evening of Thursday, August 28, 2008 at the California NanoSystems Institute at UCLA, the site of the 5th Annual World Congress of the International Brain Mapping and Intraoperative Surgical Planning Society. “The CNSI is pleased to be able to serve as the host venue for this year’s IBMISPS World Congress and I congratulate GE Healthcare for this recognition and honor,” said CNSI Interim Director Professor Leonard H. Rome.
Dr. Ron von Jako, Chief Medical Officer and Surgical Development Leader at GE Healthcare Surgery is keynote speaker at the meeting. His talk is focused on the application of electromagnetic image guidance in spine surgery. There are more than 70 speakers at this year’s meeting, including government officials from NINDS, NCI, NIBIB, TATRC, DOD, BVDIC and NASA. They’ll cover topics such as the operating room of the future, electronic medical records, biophotonics, nanoneurosurgery, nanomedicine, gene and drug delivery, robotics, multimodality imaging, diffusion tensor imaging, traumatic brain and spinal cord injury, Post Traumatic Stress Disorder (PTSD), stereotactic radiosurgery and deep brain stimulation (DBS) as well as healthcare policies related to the image guided therapy.
IBMISPS is a non-profit society organized for the purpose of encouraging basic and clinical scientists who are interested or active in areas of Brain Mapping (BM) and Intra-operative Surgical planning (ISP) to share their findings with other physicians and scientists across the disciplines.
This society is also intended for the purpose of promoting the public welfare through the advancement of ISP and BM, by a commitment to excellence in education, and by dedication to research and scientific discovery. The mission of the association will be achieved through a multi-disciplinary collaboration of government agencies, patient advocacy groups, educational institutes and private sector (industry) brought together in order to address issues and problems related to BM and ISP and to implement new technologies to benefit patient care. WWW.IBMISPS.org
The California NanoSystems Institute (CNSI) is an integrated research center, operating jointly at UCLA and UC Santa Barbara, whose mission is to foster interdisciplinary collaborations for discoveries in nanosystems and nanotechnology; train the next generation of scientists, educators and technology leaders; and facilitate partnerships with industry, fueling the economic development and the social well-being of California, the United States and the world. The CNSI was established in 2000 with $100 million in funding from the state of California and an additional $250 million in federal research grants and industry funding. At the institute, scientists in the areas of biology, chemistry, biochemistry, physics, mathematics, computational science and engineering are measuring, modifying and manipulating the very building blocks of our world — atoms and molecules. These scientists benefit from an integrated laboratory culture enabling them to conduct dynamic research at the nanoscale, leading to significant breakthroughs in the areas of health, energy, environment and information technology. For additional information, visit www.cnsi.ucla.edu.
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.
GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
For More Information Contact